Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal for ImmunoTherapy of Cancer | journal | 3.337 Q1 | 117 | 150 | 269 | 6491 | 1982 | 241 | 8.01 | 43.27 | 36.16 | |
2 | npj Vaccines | journal | 2.527 Q1 | 47 | 51 | 50 | 2652 | 236 | 48 | 4.72 | 52.00 | 42.75 | |
3 | Vaccines | journal | 2.136 Q1 | 85 | 81 | 150 | 6256 | 848 | 145 | 4.94 | 77.23 | 45.43 | |
4 | PharmacoEconomics | journal | 1.942 Q1 | 118 | 121 | 332 | 4808 | 1253 | 285 | 3.17 | 39.74 | 41.48 | |
5 | International Journal of Neuropsychopharmacology | journal | 1.846 Q1 | 125 | 138 | 406 | 7958 | 1857 | 395 | 4.21 | 57.67 | 39.33 | |
6 | Expert Review of Vaccines | journal | 1.603 Q1 | 105 | 102 | 358 | 8283 | 1412 | 327 | 4.12 | 81.21 | 42.32 | |
7 | Therapeutic Advances in Neurological Disorders | journal | 1.521 Q1 | 68 | 80 | 111 | 4715 | 476 | 102 | 3.89 | 58.94 | 37.06 | |
8 | Infection and Drug Resistance | journal | 1.354 Q1 | 65 | 258 | 131 | 10627 | 532 | 128 | 3.15 | 41.19 | 43.17 | |
9 | Frontiers in Pharmacology | journal | 1.256 Q1 | 154 | 1497 | 1757 | 97013 | 7210 | 1686 | 3.87 | 64.80 | 44.28 | |
10 | Cancer Biology and Therapy | journal | 1.240 Q1 | 130 | 148 | 476 | 5074 | 1527 | 468 | 2.94 | 34.28 | 42.24 | |
11 | Cancer Chemotherapy and Pharmacology | journal | 1.199 Q1 | 122 | 230 | 816 | 7605 | 2524 | 795 | 3.14 | 33.07 | 31.53 | |
12 | Journal of Food and Drug Analysis | journal | 1.160 Q1 | 79 | 150 | 314 | 6460 | 1506 | 312 | 4.53 | 43.07 | 41.64 | |
13 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.123 Q1 | 47 | 67 | 110 | 3581 | 391 | 110 | 3.04 | 53.45 | 37.78 | |
14 | CNS Neuroscience and Therapeutics | journal | 1.122 Q1 | 91 | 137 | 352 | 7603 | 1071 | 290 | 3.00 | 55.50 | 46.80 | |
15 | Perspectives in Medicinal Chemistry | journal | 1.113 Q1 | 17 | 0 | 5 | 0 | 35 | 5 | 10.50 | 0.00 | 0.00 | |
16 | Clinical and Experimental Vaccine Research | journal | 1.022 Q1 | 19 | 18 | 21 | 847 | 75 | 19 | 3.57 | 47.06 | 41.79 | |
17 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.997 Q1 | 64 | 90 | 154 | 4065 | 547 | 152 | 3.45 | 45.17 | 41.03 | |
18 | Human Vaccines and Immunotherapeutics | journal | 0.989 Q2 | 93 | 420 | 1240 | 17103 | 2981 | 1007 | 2.37 | 40.72 | 47.25 | |
19 | Drug Design, Development and Therapy | journal | 0.986 Q2 | 94 | 378 | 1213 | 16732 | 4161 | 1188 | 3.23 | 44.26 | 40.46 | |
20 | Pharmacogenomics and Personalized Medicine | journal | 0.965 Q2 | 37 | 23 | 61 | 1180 | 199 | 58 | 3.22 | 51.30 | 50.45 | |
21 | Journal of Experimental Pharmacology | journal | 0.937 Q2 | 23 | 9 | 21 | 630 | 72 | 21 | 3.35 | 70.00 | 44.44 | |
22 | Journal of Pharmacological Sciences | journal | 0.935 Q2 | 101 | 135 | 350 | 4013 | 1020 | 348 | 2.59 | 29.73 | 34.56 | |
23 | Biomedicine and Pharmacotherapy | journal | 0.931 Q2 | 149 | 1763 | 2601 | 91881 | 9902 | 2592 | 3.85 | 52.12 | 42.09 | |
24 | Drugs in Context | journal | 0.921 Q2 | 36 | 46 | 43 | 3211 | 126 | 41 | 1.04 | 69.80 | 44.63 | |
25 | Altex | journal | 0.893 Q2 | 64 | 46 | 117 | 133 | 456 | 102 | 4.31 | 2.89 | 51.23 | |
26 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.877 Q2 | 57 | 59 | 183 | 2788 | 424 | 176 | 2.33 | 47.25 | 37.04 | |
27 | BMC pharmacology & toxicology | journal | 0.870 Q2 | 43 | 87 | 185 | 3087 | 467 | 184 | 2.32 | 35.48 | 39.29 | |
28 | Drugs in R and D | journal | 0.833 Q2 | 54 | 35 | 135 | 1089 | 371 | 128 | 2.40 | 31.11 | 40.65 | |
29 | Pharmacological Reports | journal | 0.807 Q2 | 98 | 156 | 570 | 7168 | 1720 | 565 | 2.71 | 45.95 | 48.95 | |
30 | Journal of Physiology and Pharmacology | journal | 0.791 Q2 | 89 | 91 | 270 | 5701 | 740 | 270 | 2.69 | 62.65 | 54.56 | |
31 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.781 Q2 | 92 | 161 | 595 | 7720 | 2400 | 595 | 4.36 | 47.95 | 42.47 | |
32 | Cardiovascular Therapeutics | journal | 0.780 Q2 | 54 | 63 | 179 | 2156 | 407 | 176 | 2.22 | 34.22 | 36.14 | |
33 | Pharmacognosy Reviews (discontinued) | journal | 0.767 Q2 | 68 | 30 | 66 | 2310 | 261 | 65 | 4.00 | 77.00 | 44.04 | |
34 | Biomarker Insights | journal | 0.758 Q2 | 40 | 24 | 117 | 1491 | 247 | 116 | 1.98 | 62.13 | 46.34 | |
35 | Asian Journal of Pharmaceutical Sciences | journal | 0.707 Q2 | 66 | 62 | 298 | 2318 | 928 | 295 | 2.31 | 37.39 | 45.57 | |
36 | Current Pharmaceutical Design | journal | 0.703 Q2 | 183 | 567 | 1815 | 57632 | 4871 | 1663 | 2.46 | 101.64 | 42.32 | |
37 | Saudi Pharmaceutical Journal | journal | 0.670 Q2 | 76 | 163 | 360 | 6375 | 1344 | 353 | 3.92 | 39.11 | 42.60 | |
38 | DARU, Journal of Pharmaceutical Sciences | journal | 0.658 Q2 | 58 | 24 | 104 | 897 | 337 | 98 | 2.63 | 37.38 | 43.30 | |
39 | International Journal of Immunopathology and Pharmacology | journal | 0.643 Q2 | 65 | 68 | 226 | 1580 | 506 | 196 | 2.15 | 23.24 | 42.21 | |
40 | Pharmaceutical Biology | journal | 0.625 Q2 | 88 | 81 | 923 | 3712 | 2323 | 922 | 2.59 | 45.83 | 45.41 | |
41 | Drug Metabolism and Pharmacokinetics | journal | 0.612 Q2 | 75 | 41 | 172 | 1617 | 378 | 167 | 1.88 | 39.44 | 27.78 | |
42 | EXCLI Journal | journal | 0.612 Q2 | 55 | 103 | 301 | 4830 | 673 | 252 | 1.86 | 46.89 | 38.60 | |
43 | Chinese Medicine | journal | 0.555 Q3 | 56 | 62 | 122 | 3519 | 305 | 121 | 2.52 | 56.76 | 42.42 | |
44 | Korean Journal of Physiology and Pharmacology | journal | 0.554 Q3 | 40 | 73 | 220 | 3269 | 387 | 220 | 1.80 | 44.78 | 38.89 | |
45 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.539 Q3 | 88 | 47 | 138 | 2085 | 279 | 137 | 1.61 | 44.36 | 37.31 | |
46 | Current Therapeutic Research | journal | 0.531 Q3 | 46 | 14 | 54 | 373 | 92 | 50 | 1.79 | 26.64 | 31.75 | |
47 | Journal of Toxicology | journal | 0.513 Q3 | 47 | 39 | 53 | 1989 | 131 | 53 | 2.24 | 51.00 | 44.59 | |
48 | Pharmacognosy Research (discontinued) | journal | 0.502 Q3 | 44 | 70 | 220 | 2438 | 416 | 219 | 1.76 | 34.83 | 39.93 | |
49 | Core Evidence (discontinued) | journal | 0.501 Q3 | 29 | 3 | 15 | 136 | 33 | 15 | 2.43 | 45.33 | 38.46 | |
50 | Contemporary Clinical Trials Communications | journal | 0.453 Q3 | 26 | 106 | 194 | 3628 | 205 | 191 | 1.08 | 34.23 | 50.57 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®